A

An2 Therapeutics (ANTX)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD

About An2 Therapeutics (ANTX)

AN2 Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing treatments for rare, chronic, and serious infectious diseases with high unmet needs. The Company is focused on advancing its first product candidate, epetraborole, a once... Read more

  • 9.65
  • 9.89
  • 8.90
  • 23.58
  • -35.6%
  • --
  • 0.00
  • 46.82k
  • 187M
  • 6.88
  • %
  • %

More Stock Analysis & Reports

Access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.